H. Moser

H. Moser, F. Eichler, M. Ingeholm, 2000, Proceedings 2000 IEEE EMBS International Conference on Information Technology Applications in Biomedicine. ITAB-ITIS 2000. Joint Meeting Third IEEE EMBS International Conference on Information Technol.

Childhood cerebral form of adrenoleukodystrophy: short-term effect of bone marrow transplantation on brain MR observations.

H. Moser, A. Stillman, R. Latchaw, 1994, AJNR. American journal of neuroradiology.

Multislice proton magnetic resonance spectroscopic imaging in X‐linked adrenoleukodystrophy

H. Moser, J. Duyn, P. V. van Zijl, 1994, Annals of neurology.

Adrenoleukodystrophy update: Genetics and effect of Lorenzo's oil therapy in asymptomatic patients

H. Moser, A. Bergin, J. Borel, 1994 .

The peroxisome biogenesis disorder group 4 gene, PXAAA1, encodes a cytoplasmic ATPase required for stability of the PTS1 receptor.

H. Moser, D. Valle, N. Braverman, 1996, The EMBO journal.

Ocular clinicopathologic correlation of Hallervorden-Spatz syndrome with acanthocytosis and pigmentary retinopathy.

H. Moser, W. Green, A. Clark, 1983, American journal of ophthalmology-glaucoma.

A. Update of therapies

H. Moser, 1999, Journal of Molecular Neuroscience.

Farber's disease. Light and electron microscopic study of the eye.

H. Moser, W. Green, M. Zarbin, 1985, Archives of ophthalmology.

A SIMPLE CHROMATOGRAPHIC SCREENING TEST FOR THE DETECTION OF DISORDERS OF AMINO ACID METABOLISM. A TECHNIC USING WHOLE BLOOD OR URINE COLLECTED ON FILTER PAPER.

H. Moser, M. L. Efron, D. Young, 1964, The New England journal of medicine.

A therapeutic trial of amniotic epithelial cell implantation in patients with lysosomal storage diseases.

H. Moser, H. Singer, R. Matalon, 1985, American journal of medical genetics.

Stimulation of acid ceramidase activity by saposin D.

H. Moser, Y. Kishimoto, J. O'brien, 1994, Archives of biochemistry and biophysics.

Ceramidase and ceramide synthesis in human kidney and cerebellum. Description of a new alkaline ceramidase.

H. Moser, M. Willians, M. Sugita, 1975, Biochimica et biophysica acta.

Neurodegenerative course in ceramidase deficiency (Farber disease) correlates with the residual lysosomal ceramide turnover in cultured living patient cells

H. Moser, A. Moser, R. Salvayre, 1995, Journal of the Neurological Sciences.

Acid ceramidase deficiency: Farber lipogranulomatosis, spinal muscular atrophy associated with progressive myoclonic epilepsy and peripheral osteolysis

H. Moser, K. Sandhoff, M. Beck, 2020, Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease.

Acid Ceramidase Deficiency: Farber Lipogranulomatosis and Spinal Muscular Atrophy Associated with Progressive Myoclonic Epilepsy

H. Moser, K. Sandhoff, M. Beck, 2015 .

Color vision defects in adrenomyeloneuropathy.

H. Moser, M. B. Raven, G. Sack, 1989, American journal of human genetics.

Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: similarities in phenotype and accumulation of very long chain fatty acids.

H. Moser, A. Moser, A. J. Mcadams, 1982, The Johns Hopkins medical journal.

Value of neuroimaging in metabolic diseases affecting the CNS.

H. Moser, S. Naidu, 1991, AJNR. American journal of neuroradiology.

Normal cholesterol synthesis in human cells requires functional peroxisomes.

Victoria J. Hodge, H. Moser, S. Subramani, 1991, Biochemical and biophysical research communications.

Neuronal lipidosis and neuroaxonal dystrophy in cerebro-hepato-renal (Zellweger) syndrome

H. Moser, A. Moser, R. Kelley, 2004, Acta Neuropathologica.

X‐linked adrenoleukodystrophy presenting as neurologically pure familial spastic paraparesis

H. Moser, T. Maris, M. Tzagournissakis, 1995, Neurology.

Neonatal adrenoleukodystrophy Impaired plasmalogen biosynthesis and peroxisomal β-oxidation due to a deficiency of catalase-containing particles (peroxisomes) in cultured skin fibroblasts

H. Moser, R. Schutgens, R. Wanders, 1987, Journal of the Neurological Sciences.

The manifesting carrier in Duchenne muscular dystrophy

H. Moser, A. Emery, 1974, Clinical genetics.

Anti-Ganglioside Antibodies Bind with Enhanced Affinity to Gangliosides Containing Very Long Chain Fatty Acids

H. Moser, A. Moser, R. Schnaar, 2002, Neurochemical Research.

Identification of PEX10, the gene defective in complementation group 7 of the peroxisome-biogenesis disorders.

H. Moser, D. Valle, S. Gould, 1998, American journal of human genetics.

The nosology of mental retardation: including the report of a survey of 1378 mentally retarded individuals at the Walter E. Fernald State School.

H. Moser, P. Wolf, P. Wolf, 1971, Birth defects original article series.

Nerve conduction studies in adrenomyeloneuropathy.

H. Moser, D. Cornblath, V. Chaudhry, 1996, Journal of neurology, neurosurgery, and psychiatry.

Peroxisomal straight-chain Acyl-CoA oxidase and D-bifunctional protein are essential for the retroconversion step in docosahexaenoic acid synthesis.

H. Moser, A. Moser, P. Watkins, 2001, The Journal of biological chemistry.

Myopathy in an infant with a fatal peroxisomal disorder.

H. Moser, W. Nyhan, N. Datta, 1986, Pediatric neurology.

Fetal cerebrohepatorenal (Zellweger) syndrome: dysmorphic, radiologic, biochemical, and pathologic findings in four affected fetuses.

H. Moser, A. Moser, J. Frías, 1985, Human pathology.

Photosensitized killing of cultured fibroblasts from patients with peroxisomal disorders due to pyrene fatty acid-mediated ultraviolet damage.

H. Moser, A. Moser, G. Hoefler, 1991, The Journal of clinical investigation.

Niemann-Pick Disease—Type C: Ocular Histopathologic and Electron Microscopic Studies

H. Moser, H. Singer, W. Green, 1985 .

Late-onset metachromatic leukodystrophy

H. Moser, A. Moser, N. Baumann, 2006, Neurology.

Solvent Vapor Abuse Leukoencephalopathy. Comparison to Adrenoleukodystrophy

H. Moser, A. Moser, K. Nolte, 1994, Journal of neuropathology and experimental neurology.

Isolation of the human PEX12 gene, mutated in group 3 of the peroxisome biogenesis disorders

H. Moser, D. Valle, S. Gould, 1997, Nature Genetics.

Neurodystrophies and neurolipidoses

H. Moser, G. Bruyn, P. Vinken, 1996 .

Estimation of the phospholipid phosphorus turnover time in man: studies in normal individuals, in patients with the nephrotic syndrome and in other types of hyperlipemia.

H. Moser, K. Emerson, 1955, The Journal of clinical investigation.

The PEX Gene Screen: molecular diagnosis of peroxisome biogenesis disorders in the Zellweger syndrome spectrum.

H. Moser, A. Moser, G. Cutting, 2004, Molecular genetics and metabolism.

Inhibition of peroxisomal functions due to oxidative imbalance induced by mistargeting of catalase to cytoplasm is restored by vitamin E treatment in skin fibroblasts from Zellweger syndrome-like patients.

H. Moser, Ashish K. Sharma, Mushfiquddin Khan, 2004, Molecular genetics and metabolism.

New approaches to therapy

H. Moser, 2007, Journal of Molecular Neuroscience.

The red-green visual pigment gene region in adrenoleukodystrophy.

H. Moser, J. Mandel, J. Kaplan, 1990, American journal of human genetics.

Nerve conduction studies in the Twitcher mouse (murine globoid cell leukodystrophy)

H. Moser, R. F. Mayer, A. Yeager, 1986, Journal of the Neurological Sciences.

Brain, liver, and adipose tissue erucic and very long chain fatty acid levels in adrenoleukodystrophy patients treated with glyceryl trierucate and trioleate oils (Lorenzo's Oil)

H. Moser, A. Moser, J. Borel, 1994, Neurochemical Research.

Properties of acid ceramidase from human spleen.

H. Moser, J. Tager, A. Schram, 1989, Biochimica et biophysica acta.

Identification of a fatty acid delta6-desaturase deficiency in human skin fibroblasts.

H. Moser, G. Raymond, A. A. Spector, 2001, Journal of lipid research.

Progressive cavitating leukoencephalopathy: A novel childhood disease

H. Moser, S. Dimauro, A. Hamosh, 2005, Annals of neurology.

Plasma exchange removes glycosphingolipid in Fabry disease.

H. Moser, A. Moser, R. Pyeritz, 1980, American journal of medical genetics.

Prolonged survival and remyelination after hematopoietic cell transplantation in the twitcher mouse.

H. Moser, A. Yeager, G. Santos, 1984, Science.

ImprovedThin-LayerChromatographicMethodin the Diagnosisof Mannosidosis

H. Moser, Marcia A. Williams, E. Kolodny, 2004 .

Improved thin-layer chromatographic method in the diagnosis of mannosidosis.

H. Moser, E. Kolodny, R. Friedman, 1978, Clinical chemistry.

Farber's lipogranulomatosis. Report of a case and demonstration of an excess of free ceramide and ganglioside.

H. Moser, H. Wolfe, A. Prensky, 1969, The American journal of medicine.

BRAIN LIPIDS, PROTEOLIPIDS, AND FREE AMINO ACIDS IN MAPLE SYRUP URINE DISEASE *

H. Moser, A. Prensky, 1966, Journal of neurochemistry.

Altered expression of ALDP in X-linked adrenoleukodystrophy.

H. Moser, A. Moser, K. Smith, 1995, American journal of human genetics.

Pompe disease in Austria: clinical, genetic and epidemiological aspects

H. Moser, W. Löscher, W. Schmidt, 2017, Journal of Neurology.

Solubilization and partial purification of steroid sulfatase from rat liver: characterization of estrone sulfatase.

H. Moser, Y. Kishimoto, M. Iwamori, 1976, Archives of biochemistry and biophysics.

Early manifestations of multiple sulfatase deficiency.

H. Moser, A. Moser, R. Burk, 1984, The Journal of pediatrics.

Plasma and Red Blood Cell Fatty Acids in Peroxisomal Disorders

H. Moser, A. Moser, G. Raymond, 1999, Neurochemical Research.

Successful immunocytochemical localization of myelin components in paraffin sections of human nervous tissue with preliminary observations on multiple sclerosis and metachromatic leukodystrophy lesions.

H. Moser, Y. Itoyama, N. Sternberger, 1978, Transactions of the American Neurological Association.

Quantltatlon of Urinary GAGs and Resolution of Dermatan Sulfate from Urine of a Patient with Hunter Syndrome

H. Moser, R. Burlingame, G. Thomas, 2004 .

Direct quantitation of glycosaminoglycans in 2 mL of urine from patients with mucopolysaccharidoses.

H. Moser, R. Burlingame, G. Thomas, 1981, Clinical chemistry.

Rett syndrome--natural history in 70 cases.

H. Moser, J. Opitz, S. Naidu, 1986, American journal of medical genetics. Supplement.

A PEX10 defect in a patient with no detectable defect in peroxisome assembly or metabolism in cultured fibroblasts

H. Moser, A. Moser, G. Raymond, 2009, Journal of Inherited Metabolic Disease.

Abnormal myelination in a patient with deletion 14q11.2q13.1.

H. Moser, K. Lövblad, L. Remonda, 2000, Pediatric neurology.

A question of culture

H. Moser, 1995, Nature Medicine.

Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy

H. Moser, E. Melhem, G. Raymond, 2003, Neurology.

Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999.

H. Moser, K. Dusenbery, S. Kato, 2004, Blood.

Allogeneic bone marrow transplantation in adrenoleukodystrophy: clinical, pathologic, and biochemical studies.

H. Moser, A. Yeager, R. Saral, 1986, Birth defects original article series.

Low-density particles (W-particles) containing catalase in Zellweger syndrome and normal fibroblasts.

H. Moser, K. Tada, R. Kelley, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Quantitative magnetic resonance imaging in Rett syndrome.

H. Moser, T. Goldberg, J. Kleinman, 1991, The Journal of neuropsychiatry and clinical neurosciences.

A case of lipogranulomatosis Farber: some clinical and ultrastructural aspects

H. Moser, H. Goebel, K. Held, 2004, European Journal of Pediatrics.

Note on Rett syndrome symposium

H. Moser, 1985, Brain and Development.

Behavioral treatment of sleep dysfunction in patients with the rett syndrome

H. Moser, C. Piazza, W. Fisher, 1991, Brain and Development.

Auditory evoked brainstem response and high‐performance liquid chromatography sulfatide assay as early indices of metachromatic leukodystrophy

F. R. Brown, H. Moser, A. Moser, 1981, Neurology.

Dendritic Anomalies in Disorders Associated with Mental Retardation

Hugo W. Moser, Walter E. Kaufmann, H. Moser, 2000 .

Adrenoleukodystrophy: Impaired Oxidation of Very Long Chain Fatty Acids in White Blood Cells, Cultured Skin Fibroblasts, and Amniocytes

H. Moser, I. Singh, Y. Kishimoto, 1984, Pediatric Research.

Specific tritium labeling of cerebrosides at the 3-positions of erythro-sphingosine and threo-sphingosine.

H. Moser, Y. Kishimoto, M. Iwamori, 1975, Journal of lipid research.

The Dorsal Root Ganglia in Adrenomyeloneuropathy: Neuronal Atrophy and Abnormal Mitochondria

H. Moser, A. Moser, E. Richfield, 2001, Journal of neuropathology and experimental neurology.

Research on Rett Syndrome: Strategy and Preliminar Results

H. Moser, D. Price, J. Troncoso, 1988, Journal of child neurology.

Proton MR spectroscopic imaging predicts lesion progression on MRI in X-linked adrenoleukodystrophy

H. Moser, F. Eichler, G. Raymond, 2002, Neurology.

Cerebellar atrophy in chronic rhizomelic chondrodysplasia punctata: a potential role for phytanic acid and calcium in the death of its Purkinje cells

H. Moser, A. Moser, J. Powers, 1999, Acta Neuropathologica.

Prenatal diagnosis of rhizomelic chondrodysplasia punctata due to isolated alkyldihydroacetonephosphate acyltransferase synthase deficiency

H. Moser, A. Moser, D. Rimoin, 1999, Prenatal diagnosis.

Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata

H. Moser, A. Moser, C. Obie, 1997, Nature Genetics.

Arachidonic acid metabolism in fibroblasts from patients with peroxisomal diseases: response to interleukin 1.

H. Moser, C. Tiffany, R. Burch, 1990, Biochimica et biophysica acta.

Elevated plasma adrenocorticotropin concentration as evidence of limited adrenocortical reserve in patients with adrenomyeloneuropathy.

H. Moser, P. Ladenson, L. Blevins, 1994, The Journal of clinical endocrinology and metabolism.

Adrenoleukodystrophy: Survey of 303 cases: Biochemistry, diagnosis, and therapy

H. Moser, I. Singh, P. O'Neill, 1984, Annals of neurology.

Visual evoked potentials in adrenolukodystrophy: A trial with glycerol trioleate and Lorenzo oil

R. Tusa, H. Moser, P. Kaplan, 1993, Annals of neurology.

Neurometabolic disease.

H. Moser, 1998, Current opinion in neurology.

X-linked adrenoleukodystrophy

H. Moser, G. Raymond, A. Mahmood, 1993, Clinical Neurology and Neurosurgery.

Therapy of X-linked adrenoleukodystrophy

H. Moser, 2006 .

Adreno-leukodystrophy: Oxidative Stress of Mice and Men

H. Moser, A. Moser, P. Watkins, 2005, Journal of neuropathology and experimental neurology.

Adrenoleukodystrophy: Incidence, new mutation rate, and results of extended family screening

H. Moser, A. Moser, G. Raymond, 2001, Annals of neurology.

Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls

H. Moser, A. Moser, G. Raymond, 1999, Annals of neurology.

Peroxisomal L-Pipecolic Acid Oxidation Is Deficient in Liver from Zellweger Syndrome Patients

H. Moser, D. Danks, A. Poulos, 1989, Pediatric Research.

Preliminary observations on the occurrence of cholesterol sulfate in man.

H. Moser, A. Moser, J. C. Orr, 1966, Biochimica et biophysica acta.

3-Ketosphingolipids: application to the determination of sphingolipids which contain 4-sphingenine.

H. Moser, Y. Kishimoto, R. McCluer, 1975, Biochimica et biophysica acta.

Studies on the biosynthesis of glycolipides and other lipides of the brain.

H. Moser, M. Karnovsky, 1959, The Journal of biological chemistry.

The biochemical defect in Farber's disease.

H. Moser, J. Sidbury, A. Milunsky, 1976, Advances in experimental medicine and biology.

Ceramidase Deficiency in Farber's Disease (Lipogranulomatosis)

H. Moser, M. Sugita, J. Dulaney, 1972, Science.

A fibroblast cell line defective in alkyl-dihydroxyacetone phosphate synthase: a novel defect in plasmalogen biosynthesis.

H. Moser, A. Moser, A. Das, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Sulfatide and sphingomyelin loading of living cells as tools for the study of ceramide turnover by lysosomal ceramidase--implications for the diagnosis of Farber disease.

H. Moser, A. Moser, R. Salvayre, 1995, Biochemical and molecular medicine.

PRENATAL DIAGNOSIS OF FARBER'S DISEASE

H. Moser, A. Moser, P. Benson, 1979, The Lancet.

Analysis and quantitation of free ceramide containing nonhydroxy and 2-hydroxy fatty acids, and phytosphingosine by high-performance liquid chromatography.

H. Moser, M. Iwamori, C. Costello, 1979, Journal of lipid research.

Diagnosis of lipogranulomatosis (Farber disease) by use of cultured fibroblasts.

H. Moser, J. Sidbury, A. Milunsky, 1976, The Journal of pediatrics.

High performance liquid chromatography of ceramides: application to analysis in human tissues and demonstration of ceramide excess in Farber's disease.

H. Moser, J. Evans, R. McCluer, 1974, Journal of lipid research.

Application of "high-performance" liquid chromatography to the study of sphingolipidoses.

H. Moser, R. Pyeritz, D. Wenger, 1980, Clinical chemistry.

Reverse Phase High‐Performance Liquid Chromatography of Cerebrosides, Sulfatides and Ceramides: Microanalysis of Homolog Composition Without Hydrolysis and Application to Cerebroside Analysis in Peripheral Nerves of Adrenoleukodystrophy Patients

H. Moser, Y. Kishimoto, S. Yahara, 1980, Journal of neurochemistry.

Fatty acid composition of free ceramides of kidney and cerebellum from a patient with Farber's disease

H. Moser, M. Sugita, J. Dulaney, 1973, Lipids.

Phenotypic variability in siblings with Farber disease.

H. Moser, S. Antonarakis, S. Qualman, 1984, The Journal of pediatrics.

Ceramide and Ganglioside Accumulation in Farber's Lipogranulomatosis.∗

H. Moser, A. Prensky, S. Carr, 1967 .

Above-normal urinary excretion of urinary ceramides in Farber's disease, and characterization of their components by high-performance liquid chromatography.

H. Moser, M. Iwamori, 1975, Clinical chemistry.

Human acid ceramidase gene: novel mutations in Farber disease.

H. Moser, A. Moser, D. Zimonjic, 2000, Molecular genetics and metabolism.

Farber disease: pathologic diagnosis in sibs with phenotypic variability.

H. Moser, S. Antonarakis, J. Boitnott, 1987, American journal of medical genetics. Supplement.

Duchenne muscular dystrophy: Pathogenetic aspects and genetic prevention

H. Moser, H. Moser, 2004, Human Genetics.

A mouse model for X-linked adrenoleukodystrophy.

H. Moser, A. Moser, K. Smith, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy.

H. Moser, Y. Kishimoto, J. Hamilton, 1995, The Journal of clinical investigation.

Structural and Chemical Alterations in the Cerebral Maldevelopment of Fetal Cerebro‐Hepato-Renal (Zellweger) Syndrome

H. Moser, A. Moser, V. Caviness, 1989, Journal of neuropathology and experimental neurology.

CHANGES IN THE AMINO ACID COMPOSITION OF PROTEOLIPIDS OF WHITE MATTER DURING MATURATION OF THE HUMAN NERVOUS SYSTEM *

H. Moser, A. Prensky, 1967, Journal of neurochemistry.

Argininosuccinic aciduria: Report of two new cases and demonstration of intermittent elevation of blood ammonia

H. Moser, C. Neumann, M. L. Efron, 1967 .

Modification of the schedule of myelination in the rat by early nutritional deprivation.

H. Moser, P. Dodge, J. Benton, 1966, Pediatrics.

Evolution of phenotypes in adult male patients with X‐linked adrenoleukodystrophy

H. Moser, G. Raymond, D. Loes, 2001, Annals of neurology.

Incidence of X-linked adrenoleukodystrophy and the relative frequency of its phenotypes.

H. Moser, L. Bezman, Hugo W. Moser, 1998, American journal of medical genetics.

Apparent biochemical homozygosity in two obligatory heterozygotes for metachromatic leukodystrophy.

H. Moser, I. Lott, D. Hoefnagel, 1976, The Journal of pediatrics.

A sibship with a mild variant of Zellweger syndrome

H. Moser, R. Wanders, R. Schutgens, 1987, Journal of Inherited Metabolic Disease.

Infantile Refsum's disease: Biochemical findings suggesting multiple peroxisomal dysfunction

H. Moser, R. Wanders, R. Schutgens, 1986, Journal of Inherited Metabolic Disease.

Genetic and Phenotypic Heterogeneity in Disorders of Peroxisome Biogenesis—A Complementation Study Involving Cell Lines from 19 Patients

H. Moser, A. Moser, A. Roscher, 1989, Pediatric Research.

Phenotypic and genotypic variability of generalized peroxisomal disorders.

H. Moser, S. Naidu, A. Moser, 1988, Pediatric neurology.

Hyperpipecolic acidemia in neonatal adrenoleukodystrophy.

H. Moser, R. Kelley, Hugo W. Moser, 1984, American journal of medical genetics.

Peroxisomal Disorders: Genotype, Phenotype, Major Neuropathologic Lesions, and Pathogenesis

H. Moser, J. Powers, H. Moser, 1998 .

Evaluation of Therapy of X-Linked Adrenoleukodystrophy

Xavier Golay, Hugo W. Moser, Seth Smith, 2004, Neurochemical Research.

Lorenzo's oil.

H. Moser, H. Moser, 1993, Lancet.

Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters

Jean Mosser, Hugo Moser, Jean-Louis Mandel, 1993, Nature.

The cerebrohepatorenal (Zellweger) syndrome. Increased levels and impaired degradation of very-long-chain fatty acids and their use in prenatal diagnosis.

H. Moser, R. Kelley, F. R. Brown, 1984, The New England journal of medicine.

Peroxisome biogenesis disorders.

H. Moser, A. Moser, G. Raymond, 2006, Biochimica et biophysica acta.

Combined liquid chromatography-tandem mass spectrometry as an analytical method for high throughput screening for X-linked adrenoleukodystrophy and other peroxisomal disorders: preliminary findings.

Hugo Moser, H. Moser, A. Moser, 2006, Molecular genetics and metabolism.

Mutations in novel peroxin gene PEX26 that cause peroxisome-biogenesis disorders of complementation group 8 provide a genotype-phenotype correlation.

H. Moser, A. Moser, N. Shimozawa, 2003, American journal of human genetics.

Mutation analysis of PEX7 in 60 probands with rhizomelic chondrodysplasia punctata and functional correlations of genotype with phenotype

P. K. Chakraborty, H. Moser, A. Moser, 2002, Human mutation.

Mutations in PEX1 are the most common cause of peroxisome biogenesis disorders

H. Moser, D. Valle, S. Gould, 1997, Nature Genetics.

Phytanoyl-CoA hydroxylase is present in human liver, located in peroxisomes, and deficient in Zellweger syndrome: direct, unequivocal evidence for the new, revised pathway of phytanic acid alpha-oxidation in humans.

H. Moser, S. Denis, R. Wanders, 1996, Biochemical and biophysical research communications.

Standardization of complementation grouping of peroxisome-deficient disorders and the second Zellweger patient with peroxisomal assembly factor-1 (PAF-1) defect.

H. Moser, A. Moser, R. Wanders, 1993, American journal of human genetics.

The cerebro‐hepato‐renal (Zellweger) syndrome: Prenatal detection based on impaired biosynthesis of plasmalogens

H. Moser, R. Wanders, R. Schutgens, 1985, Prenatal diagnosis.

Prenatal diagnosis of Zellweger cerebrohepatorenal syndrome.

H. Moser, A. Moser, L. Jackson, 1985, The New England journal of medicine.

The Prenatal Diagnosis of Adrenoleukodystrophy. Demonstration of Increased Hexacosanoic Acid Levels in Cultured Amniocytes and Fetal Adrenal Gland

B. Migeon, H. Moser, A. Moser, 1982, Pediatric Research.

Peroxisomal integral membrane proteins in livers of patients with Zellweger syndrome, infantile Refsum's disease and X-linked adrenoleukodystrophy

H. Moser, D. Danks, A. Poulos, 1988, Journal of Inherited Metabolic Disease.

Therapeutic trial of plasmapheresis in Refsum disease and in Fabry disease.

H. Moser, R. Pyeritz, H. Braine, 1980, Birth defects original article series.

Long Chain Fatty Acids and Peroxisomal Disorders

H. Moser, A. Moser, 2006 .

Adrenoleukodystrophy and other peroxisomal disorders that affect the nervous system, including new observations on L-pipecolic acid oxidase in primates

H. Moser, P. Watkins, S. Mihalik, 1989, Brain and Development.

Neonatal seizures and retardation in a girl with biochemical features of X‐linked adrenoleukodystrophy

H. Moser, A. Moser, T. Hashimoto, 1988, Neurology.

New approaches in peroxisomal disorders.

H. Moser, 1987, Developmental neuroscience.

The prenatal diagnosis of the cerebro‐hepato‐renal syndrome of Zellweger

H. Moser, A. Moser, George I. Solish, 1985, Prenatal diagnosis.

Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy.

H. Moser, S. Goldfischer, I. Singh, 1984, Proceedings of the National Academy of Sciences of the United States of America.

The 22-kD Peroxisomal Integral Membrane Protein in Zellweger Syndrome—Presence, Abundance, and Association with a Peroxisomal Thiolase Precursor Protein

H. Moser, S. Mihalik, R. Kelley, 1991, Pediatric Research.

Diagnosis and Follow-Up of a Case of Peroxisomal Disorder With Peroxisomal Mosaicism

H. Moser, R. Wanders, F. Roels, 1999, Journal of child neurology.

Very long chain fatty acid oxidation in rat liver.

H. Moser, Y. Kishimoto, N. Kawamura, 1981, Biochemical and biophysical research communications.

Infantile Refsum disease.

H. Moser, S. Naidu, 1991, AJNR. American journal of neuroradiology.

The peroxisome

H. Moser, 1988, Neurology.

Study of peroxisomal proteins in patients with zellweger syndrome

H. Moser, J. Gärtner, W. Chen, 1990, Journal of Inherited Metabolic Disease.

Complementation study of peroxisome-deficient disorders by immunofluorescence staining and characterization of fused cells

H. Moser, T. Hashimoto, N. Shimozawa, 1992, Human Genetics.

Peroxisomal ghosts are intracellular structures distinct from lysosomal compartments in Zellweger Syndrome: A confocal laser scanning microscopy study

H. Moser, A. Moser, P. Lazarow, 2000, Biology of the cell.

Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders.

H. Moser, A. Moser, S. Gould, 1995, Journal of cell science.

Analysis of Peroxisomes in Lymphoblasts: Zellweger Syndrome and a Patient with a Deletion in Chromosome 7

H. Moser, A. Moser, P. Lazarow, 1993, Pediatric Research.

Peroxisome assembly mutations in humans: Structural heterogeneity in Zellweger syndrome

H. Moser, A. Moser, P. Lazarow, 1992, Journal of cellular physiology.

Mutations in the 70K peroxisomal membrane protein gene in Zellweger syndrome

H. Moser, D. Valle, J. Gärtner, 1992, Nature Genetics.

Chapter 18 Lessons for peroxisome biogenesis from fluorescence analyses of Zellweger syndrome fibroblasts

H. Moser, P. Lazarow, Manuel J. Santos, 1992 .

Peroxisomal disorders: complementation analysis using beta-oxidation of very long chain fatty acids.

H. Moser, A. Moser, P. Watkins, 1990, Biochemical and biophysical research communications.

Presence of the peroxisomal 22-kDa integral membrane protein in the liver of a person lacking recognizable peroxisomes (Zellweger syndrome).

H. Moser, P. Watkins, Y. Fujiki, 1986, Proceedings of the National Academy of Sciences of the United States of America.

X-Linked Adrenoleukodystrophy: Overview and Prognosis as a Function of Age and Brain Magnetic Resonance Imaging Abnormality. A Study Involving 372 Patients

H. Moser, E. Melhem, G. Raymond, 2000, Neuropediatrics.

Determination of 30 X‐linked adrenoleukodystrophy mutations, including 15 not previously described

H. Moser, H. Seuánez, A. Moser, 2000, Human mutation.

Accurate DNA-based diagnostic and carrier testing for X-linked adrenoleukodystrophy.

H. Moser, C. Boehm, G. Cutting, 1999, Molecular genetics and metabolism.

The prenatal diagnosis of X‐linked adrenoleukodystrophy

H. Moser, A. Moser, 1999, Prenatal diagnosis.

Clinical aspects of adrenoleukodystrophy and adrenomyeloneuropathy.

H. Moser, A. Moser, A. Bergin, 1991, Developmental neuroscience.

Childhood adrenoleukodystrophy. Failure of intensive immunosuppression to arrest neurologic progression.

H. Moser, D. Griffin, M. Bresnan, 1988, Archives of neurology.

Zellweger Syndrome Amniocytes: Morphological Appearance and a Simple Sedimentation Method for Prenatal Diagnosis

H. Moser, A. Moser, H. Shio, 1988, Pediatric Research.

Peroxisomal beta-oxidation enzyme proteins in adrenoleukodystrophy: distinction between X-linked adrenoleukodystrophy and neonatal adrenoleukodystrophy.

H. Moser, T. Hashimoto, P. Watkins, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts and correlation with disease expression in three generations of a kindred.

H. Moser, B. O'neill, L. C. Marmion, 1982, Neurology.

Adrenoleukodystrophy: natural history, treatment and outcome

H. Moser, 1995, Journal of Inherited Metabolic Disease.

Adrenoleukodystrophy: Phenotypic variability and implications for therapy

H. Moser, A. Moser, J. Ott, 1992, Journal of Inherited Metabolic Disease.

Identification of female carriers of adrenoleukodystrophy.

H. Moser, J. Trojak, A. Moser, 1983, The Journal of pediatrics.

Familial X‐linked Addison disease as an expression of adrenoleukodystrophy (ALD)

H. Moser, B. O'neill, K. Saxena, 1982, Neurology.

Urinary bile acids and peroxisomal bifunctional enzyme deficiency.

H. Moser, A. Moser, J. Evans, 1996, American journal of medical genetics.

STEROID SULFATASE IN BRAIN: COMPARISON OF SULFOHYDROLASE ACTIVITIES FOR VARIOUS STEROID SULFATES IN NORMAL AND PATHOLOGICAL BRAINS, INCLUDING THE VARIOUS FORMS OF METACHROMATIC LEUKODYSTROPHY

H. Moser, Y. Kishimoto, M. Iwamori, 1976, Journal of neurochemistry.

Cholesterol sulfate in rat tissues. Tissue distribution, developmental change and brain subcellular localization.

H. Moser, Y. Kishimoto, M. Iwamori, 1976, Biochimica et biophysica acta.

Liver Glycolipids, Steroid Sulfates and Steroid Sulfatases in a Form of Metachromatic Leukodystrophy Associated with Multiple Sulfatase Deficiencies

H. Moser, Marcia A. Williams, M. Harbison, 1972 .

The Chemical Pathology of Krabbe Disease and Metachromatic Leucodystrophy1

H. Moser, M. Lees, 1962 .

New sites of ocular involvement in late-infantile metachromatic leukodystrophy revealed by histopathologic studies

H. Moser, W. Green, I. Scott, 1993, Graefe's Archive for Clinical and Experimental Ophthalmology.

Sulfate metabolism in metachromatic leukodystrophy.

H. Moser, G. McKhann, A. Moser, 1964, Transactions of the American Neurological Association.

The Inflammatory Myelinopathy of Adreno‐Leukodystrophy: Cells, Effector Molecules, and Pathogenetic Implications

H. Moser, A. Moser, Yan Liu, 1992, Journal of neuropathology and experimental neurology.

Hyperuricemia in Down's syndrome.

H. Moser, S. Krane, S. S. Pant, 1968, The Journal of clinical endocrinology and metabolism.

Therapy of X-linked adrenoleukodystrophy

H. Moser, 2006, NeuroRX.

“Lorenzo’s Oil” Therapy for X-linked Adrenoleukodystrophy: Rationale and Current Assessment of Efficacy

H. Moser, A. Moser, G. Raymond, 2007, Journal of Molecular Neuroscience.

Evaluation of the preventive effect of glyceryl trioleate-trierucate ("Lorenzo's oil") therapy in X-linked adrenoleukodystrophy: results of two concurrent trials.

H. Moser, G. Raymond, F. Hanefeld, 2003, Advances in experimental medicine and biology.

Adrenoleukodystrophy: effects of dietary restriction of very long chain fatty acids and of administration of carnitine and clofibrate on clinical status and plasma fatty acids.

H. Moser, A. Moser, W. Rizzo, 1982, The Johns Hopkins medical journal.

Progress in X-linked adrenoleukodystrophy

H. Moser, P. Dubey, A. Fatemi, 2004, Current opinion in neurology.

Chapter 34 – Adrenoleukodystrophies

H. Moser, 2004 .

ABCD1 mutations and the X‐linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlations

H. Moser, G. Raymond, H. Waterham, 2001, Human mutation.

Chapter 52 – Peroxisomal Disorders

H. Moser, 1999 .

Adrenoleukodystrophy: Molecular Genetics, Pathology, and Lorenzo's oil

H. Moser, J. Powers, Kirby D. Smith, 1995, Brain pathology.

Suspended judgment. Reactions to the motion picture "Lorenzo's Oil".

H. Moser, Hugo W. Moser, 1994, Controlled clinical trials.

Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy.

H. Moser, H W Moser, H. Moser, 1997, Brain : a journal of neurology.

Mutational analysis of patients with X‐linked adrenoleukodystrophy

H. Moser, S. Zheng, J. Mandel, 1995, Human mutation.

Phospholipids in X-linked adrenoleukodystrophy white matter: fatty acid abnormalities before the onset of demyelination

Hugo W. Moser, James M. Powers, Ann B. Moser, 1992, Journal of the Neurological Sciences.

Cognitive impairment in adult-onset adrenoleukodystrophy.

H. Moser, L. Speedie, D. Edwin, 1990, Molecular and chemical neuropathology.

Adrenoleukodystrophy: Biochemical procedures in diagnosis, prevention and treatment

H. Moser, P. Watkins, S. Naidu, 1987, Journal of Inherited Metabolic Disease.

Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy* Dedicated to the memory of Peter Moser

H. Moser, 1997 .

Galactosylceramide-β-Galactosidase Deficiency in Association with Cherry Red Spot

H. Moser, I. Maumenee, D. Wenger, 1988, Neuropediatrics.

Presumptive monosomy 21 with neuronal migration disorder re-diagnosed as de novo unbalanced translocation t(18p;21q) by fluorescence in situ hybridisation.

H. Moser, L. Remonda, G. Ramelli, 2002, Genetic counseling.

REVIEW ARTICLE Stem Cell-Based Therapies for Spinal Cord Injury

H. Moser, R. Tewarie, Andrés Hurtado, 2009 .

Mutations in the Peroxin Pex26p Responsible for Peroxisome Biogenesis Disorders of Complementation Group 8 Impair Its Stability, Peroxisomal Localization, and Interaction with the Pex1p·Pex6p Complex*

Ann Moser, H. Moser, A. Moser, 2006, Journal of Biological Chemistry.

Genotype-phenotype correlations in disorders of peroxisome biogenesis.

H. Moser, 1999, Molecular genetics and metabolism.

Metabolic control of peroxisome abundance.

Daniel E. Warren, S. South, H. Moser, 1999, Journal of cell science.

Genomic structure and identification of 11 novel mutations of the PEX6 (peroxisome assembly factor‐2) gene in patients with peroxisome biogenesis disorders

H. Moser, R. Wanders, G. Besley, 1999, Human mutation.

Clinical and therapeutic aspects of adrenoleukodystrophy and adrenomyeloneuropathy.

H. Moser, 1995, Journal of neuropathology and experimental neurology.

Compound heterozygosity for metachromatic leukodystrophy and arylsulfatase A pseudodeficiency alleles is not associated with progressive neurological disease.

H. Moser, J. Kappler, P. Propping, 1993, American journal of human genetics.

Preamble to the workshop on rett syndrome

H. Moser, J. Opitz, J. F. Reynolds, 1986 .

The peroxin Pex6p gene is impaired in peroxisomal biogenesis disorders of complementation group 6

H. Moser, A. Moser, N. Braverman, 2001, Journal of Human Genetics.

Molecular genetics of peroxisomal disorders.

H. Moser, 1998, Frontiers in bioscience : a journal and virtual library.

Distinction between peroxisomal bifunctional enzyme and acyl‐CoA oxidase deficiencies

H. Moser, A. Moser, G. Raymond, 1995, Annals of neurology.

Human and great ape red blood cells differ in plasmalogen levels and composition

H. Moser, A. Moser, J. Hacia, 2011, Lipids in Health and Disease.

Ether lipid biosynthesis: alkyl-dihydroxyacetonephosphate synthase protein deficiency leads to reduced dihydroxyacetonephosphate acyltransferase activities.

H. Moser, R. Wanders, L. Ijlst, 1999, Journal of lipid research.

Partial deletion of long arm of chromosome 11[del(11)(q23)]: Jacobsen syndrome. Two new cases and review of the clinical findings.

H. Moser, A. Schinzel, P. Auf der Maur, 1977, Journal of medical genetics.

MR findings in adult-onset adrenoleukodystrophy.

A. J. Kumar, H. Moser, A. Bergin, 1995, AJNR. American journal of neuroradiology.

Pathologic findings in adrenoleukodystrophy heterozygotes.

H. Moser, A. Moser, R. Norum, 1987, Archives of pathology & laboratory medicine.

MRI and proton MRSI in women heterozygous for X-linked adrenoleukodystrophy

H. Moser, A. Moser, L. Nagae-Poetscher, 2003, Neurology.

B. Evaluation techniques

H. Moser, 1999, Journal of Molecular Neuroscience.

Neuroimaging studies in Rett syndrome

H. Moser, G. Pearlson, X. Golay, 2001, Brain and Development.

Neuroimaging studies in Rett syndrome q

H. Moser, G. Pearlson, S. Mori, 2001 .

Increased very long chain fatty acids in patients on a ketogenic diet: a cause of diagnostic confusion.

H. Moser, A. Moser, C. Theda, 1993, The Journal of pediatrics.

Incomplete trisomy 22

H. Moser, A. Schinzel, W. Schmid, 1981, Human Genetics.

Olivopontocerebellar atrophy with retinal degeneration. A clinical and ocular histopathologic study.

H. Moser, W. Green, E. Traboulsi, 1988, Archives of ophthalmology.

Identification of differences in human and great ape phytanic acid metabolism that could influence gene expression profiles and physiological functions

Kimberly D Siegmund, Oliver A Ryder, H. Moser, 2010, BMC Physiology.

Cognitive evaluation of neurologically asymptomatic boys with X-linked adrenoleukodystrophy.

H. Moser, A. Moser, G. Raymond, 2006, Archives of neurology.

Phenotype of adult Refsum disease due to a defect in peroxin 7

H. Moser, M. Durán, D. M. van den Brink, 2007, Neurology.

Acute bilateral internal carotid artery occlusion

H. Moser, R. Ojemann, 1964, Neurology.

Prevention of Mental Retardation (Genetics)

H. Moser, 1992 .

Infusion of normal HL-A identical leukocytes in Sanfilippo disease type B. Estimate of infused cell survival by assays of alpha-N-acetylglucosaminidase activity and cytogenetic techniques: effect on glycosaminoglycan excretion in the urine.

H. Moser, P. Russell, C. Bartsocas, 1974, Archives of neurology.

Detection of the carrier state of Hurler's syndrome by assay of α-l-iduronidase in leukocytes

H. Moser, A. Milunsky, J. Dulaney, 1976 .

Cherry red spot in association with galactosylceramide-β-galactosidase deficiency

H. Moser, I. Maumenee, D. Wenger, 1987, Journal of Inherited Metabolic Disease.

Impaired Cerebroside Sulfate Hydrolysis in Fibroblasts of Sibs with “Pseudo” Arylsulfatase A Deficiency without Metachromatic Leukodystrophy

H. Moser, A. Fluharty, G. Thomas, 1983, Pediatric Research.

Administration of iduronate sulfatase by plasma exchange to patients with the Hunter syndrome: a clinical study.

C. W. Hall, H. Moser, H. Braine, 1982, American journal of medical genetics.

Adrenoleukodystrophy: Unusual Computed Tomographic Appearance

H. Moser, R. Lehman, J. Towfighi, 1982 .

Development of myelin in inherited disorders of amino acid metabolism.

H. Moser, A. Prensky, S. Carr, 1968, Archives of neurology.

A novel insert mutation in γ-sarcoglycan gene leads to severe childhood autosomal recessive muscular dystrophy

H. Moser, J. Burgunder, S. Gallati, 2002, Journal of Neurology.

X‐linked adrenoleukodystrophy: Therapeutic approaches to distinct phenotypes

H. Moser, A. Moser, P. Dubey, 2005, Pediatric transplantation.

Where has all the white matter gone?

H. Moser, E. Kaye, 2004, Neurology.

A case of combined Farber and Sandhoff disease

H. Moser, A. Sewell, A. Poulos, 1989, European Journal of Pediatrics.

Farber's lipogranulomatosis: ceramidase deficiency and prolonged survival in three relatives.

H. Moser, L. Pavone, F. Mollica, 1980, The Johns Hopkins medical journal.

Argininosuccinase deficiency in fibroblasts cultured from patients with argininosuccinic aciduria

H. Moser, J. Littlefield, V. Shih, 1969, Biochemical Genetics.

Magnetic resonance imaging detection of lesion progression in adult patients with X-linked adrenoleukodystrophy.

H. Moser, F. Eichler, G. Raymond, 2007, Archives of neurology.

Proton MR Spectroscopic Imaging in Pelizaeus-Merzbacher Disease

H. Moser, A. Beltramello, P. Barker, 2003, AJNR. American journal of neuroradiology.

The design of a diet restricted in saturated very long-chain fatty acids: therapeutic application in adrenoleukodystrophy.

H. Moser, N. Sacktor, F. R. Brown, 1984, The American journal of clinical nutrition.

Brain uptake and utilization of fatty acids

H. Moser, A. Leaf, P. Watkins, 2001, Journal of Molecular Neuroscience.

Neuropathies with Deranged Metabolism

H. Moser, 1985 .

Brain glucose metabolism in Rett Syndrome.

H. Moser, M. Johnston, D. Wong, 2002, Pediatric neurology.

Chromosomal rearrangement segregating with adrenoleukodystrophy: associated changes in color vision.

D. Krantz, M. Alpern, H. Moser, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Peroxisomal diseases.

H. Moser, 1993, Advances in human genetics.

Mutational analysis and the pathogenesis of variant X-linked adrenoleukodystrophy phenotypes.

H. Moser, K. Smith, S. Kemp, 1999, Archives of neurology.

Tumor necrosis factor-α and X-linked adrenoleukodystrophy

H. Moser, K. Smith, G. Raymond, 1995, Journal of Neuroimmunology.

Serum autoantibody responses to myelin oligodendrocyte glycoprotein and myelin basic protein in X-linked adrenoleukodystrophy and multiple sclerosis

H. Moser, T. Klockgether, C. Haase, 2001, Journal of Neuroimmunology.

X-linked adrenoleukodystrophy: the role of contrast-enhanced MR imaging in predicting disease progression.

H. Moser, E. Melhem, G. Raymond, 2000, AJNR. American journal of neuroradiology.

[Peroxisomal disorders: classification and overview of biochemical abnormalities].

H. Moser, 1999, Revista de neurologia.

Phytanoyl-CoA hydroxylase is not only deficient in classical Refsum disease but also in rhizomelic chondrodysplasia punctata

H. Moser, R. Wanders, P. Watkins, 1997, Journal of Inherited Metabolic Disease.

Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata (RCDP). • 593

H. Moser, A. Moser, C. Obie, 1997, Pediatric Research.

PEX7 gene structure, alternative transcripts, and evidence for a founder haplotype for the frequent RCDP allele, L292ter.

H. Moser, A. Moser, D. Valle, 2000, Genomics.

Peroxisomal disease cell lines with cellular plasmalogen deficiency have impaired muscarinic cholinergic signal transduction activity and amyloid precursor protein secretion.

H. Moser, A. Moser, G. Roth, 1998, Biochemical and biophysical research communications.

Characterization of phytanoyl-Coenzyme A hydroxylase in human liver and activity measurements in patients with peroxisomal disorders.

H. Moser, R. Wanders, P. Watkins, 1998, Clinica chimica acta; international journal of clinical chemistry.

Peroxisomal bifunctional protein deficiency revisited: resolution of its true enzymatic and molecular basis.

T Hashimoto, H. Moser, R. Wanders, 1999, American journal of human genetics.

1590 DEMYELINATION IN PELIZAEUS-MERZBACHER DISEASE

H. Moser, R. Herndon, I. Lott, 1981, Pediatric Research.

Very long-chain fatty acids in diagnosis, pathogenesis, and therapy of peroxisomal disorders

H. Moser, A. Moser, 2007, Lipids.

Endoneurial lipid composition of normal human sural nerve

H. Moser, Y. Kishimoto, Mark J. Brown, 1979, Annals of neurology.

Myelin Membrane from Adrenoleukodystrophy Brain White Matter—Biochemical Properties

H. Moser, A. Moser, D. Kirschner, 1983, Journal of neurochemistry.

gateway the newsletter of the snm molecular imaging center of excellence

Assaf A. Gilad, Keren Ziv, Michal Neeman, 2008 .

Ceramidase deficiency: Farber's lipogranulomatosis

H. Moser, W. Chen, 1983 .

Recovery From Probable Central Pontine Myelinolysis Associated With Addison's Disease

H. Moser, F. Heldrich, R. Kandt, 1983 .

Uniparental origin of sex chromosome polysomies.

H. Moser, A. Schinzel, W. Rosenkranz, 1992, Human Heredity.

Auditory function in adrenomyeloneuropathy

H. Moser, G. Raymond, J. Pillion, 2008, Journal of the Neurological Sciences.

Auditory brainstem response findings and peripheral auditory sensitivity in adrenoleukodystrophy

H. Moser, A. Mahmood, J. Pillion, 2006, Journal of the Neurological Sciences.

Auditory Brainstem Response and Audiologic Findings in Adrenoleukodystrophy: Its Variant and Carrier

H. Moser, S. Naidu, H. Shimizu, 1988, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Alexander disease: Combined gene analysis and MRI clarify pathogenesis and extend phenotype

H. Moser, 2005, Annals of neurology.

Sensorimotor function and axonal integrity in adrenomyeloneuropathy.

H. Moser, A. Bastian, S. Mori, 2006, Archives of neurology.

Adrenoleukodystrophy: studies of the phenotype, genetics and biochemistry.

B. Migeon, H. Moser, A. Moser, 1980, The Johns Hopkins medical journal.

Adrenoleukodystrophy (ALD): clinical and CT features of a childhood variant.

H. Moser, B. O'neill, G. Forbes, 1983, Neurology.

The peroxisome deficient PEX2 zellweger mouse

H. Moser, A. Moser, P. Faust, 2001, Journal of Molecular Neuroscience.

Adrenoleukodystrophy

H. Moser, B. O'neill, K. Saxena, 1984, Neurology.

Multiple sclerosis-like syndrome in a woman heterozygous for adrenoleukodystrophy.

H. Moser, F. Ebner, E. Körner, 1993, European neurology.

Leukodystrophies: Pathogenesis, Diagnosis, Strategies, Therapies, and Future Research Directions

H. Moser, B. Maria, S. Naidu, 2003, Journal of child neurology.

Rett syndrome--observational study of 33 families.

H. Moser, S. Naidu, M. Murphy, 1986, American journal of medical genetics. Supplement.

The Rett syndrome: Progress report on studies at the Kennedy institute

H. Moser, E. Niedermeyer, J. Troncoso, 1990, Brain and Development.

Adrenoleukodystrophy carrier state presenting as a chronic nonprogressive spinal cord disorder.

H. Moser, W. Landau, M. Noetzel, 1987, Archives of neurology.

AMNIOTIC EPITHELIAL CELL IMPLANTATION (AECI) IN LYSOSOMAL STORAGE DISEASES

H. Moser, H. Singer, R. Matalon, 1984, Pediatric Research.

Life expectancy in rhizomelic chondrodysplasia punctata

H. Moser, A. Moser, G. Raymond, 1996 .

ABNORMALITIES OF SERUM GAMMA 1A GLOBULIN AND ATAXIA TELANGIECTASIA

H. Moser, R. Young, K. Austen, 1964, Medicine.

Localized proton magnetic resonance spectroscopy in patients with adult adrenoleukodystrophy. Increase of choline compounds in normal appearing white matter.

H. Moser, N. Baumann, E. Cabanis, 1997, Archives of neurology.

Adre nole ukody strop hy

H. Moser, Y. Kishimoto, Kunihiko Suzuki, 1985 .

Peripheral nerve involvement in Krabbe disease

H. Moser, 2006, Neurology.

Brain uptake and utilization of fatty acids

H. Moser, P. Watkins, J. Hamilton, 2007, Journal of Molecular Neuroscience.

Neurochemical alterations in Rett syndrome.

H. Moser, C. Nemeroff, G. Wenk, 1993, Brain research. Developmental brain research.

Positron emission tomography in the Rett syndrome: clinical, biochemical and pathological correlates.

H. Moser, D. Wong, G. Wenk, 1992, Brain & development.

Gene therapy in neurology.

H. Moser, 1994, European neurology.

Abstracts from the Fourth Symposium on Probing Disorders of the White Matter

H. Moser, 1999 .

Neurocutaneous Disorders: Adrenoleukodystrophy

H. Moser, B. V. Geel, 2004 .

B. Other leukodystrophies

H. Moser, 1999, Journal of Molecular Neuroscience.

The pathogenesis and treatment of copper deficiency in steely-hair syndrome.

H. Moser, I. Lott, J. Kanfer, 1975, Transactions of the American Neurological Association.

87 FETAL CEREBRO-HEPATO-RENAL (ZELLWEGER) SYNDROME: NEUROPATHOLOGIC FINDINGS RELEVANT TO THE CEREBRAL MALFORMATION

H. Moser, A. Moser, V. Caviness, 1984 .

Peroxisomal disorders.

H. Moser, S. Naidu, 1994, Neurologic clinics.

A role for gene therapy in mental retardation

H. Moser, 1995 .

Hematopoietic Cell Transplantation in Murine Globoid Cell Leukodystrophy (The Twitcher Mouse)—A Model of a Human Sphingolipidosis (Krabbe Disease)

H. Moser, R. F. Mayer, Y. Kishimoto, 1988 .

Improvement of clinical and MM findings in a boy with adrenoleukodystrophy by dietary erucic acid therapy

H. Moser, Yasuyuki Suzuki, T. Orii, 1992, Brain and Development.

A human-murine chimera model for in utero human hematopoietic stem cell transplantation.

H. Moser, C. Civin, K. Blakemore, 1999, Biology of Blood and Marrow Transplantation.

Peroxisomal Disorders: Genotype, Phenotype, Major Neuropathologic Lesions, and Pathogenesis

H. Moser, J. Powers, 1999 .

Spectroscopic evidence of cerebral axonopathy in patients with “pure” adrenomyeloneuropathy

H. Moser, A. Bastian, G. Raymond, 2005, Neurology.

Komrower Lecture. Adrenoleukodystrophy: natural history, treatment and outcome.

H. Moser, 1995, Journal of inherited metabolic disease.

Cerebrotendinous xanthomatosis: in vivo labeling of cerebral sterols and sterol esters.

H. Moser, Y. Kishimoto, B. Derby, 1971, Transactions of the American Neurological Association.

Cerebrotendinous Xanthomatosis: A Clinicopathological Biochemical and Metabolic Study

H. Moser, E. Richardson, B. Derby, 1970 .

Improved tissue characterization in adrenoleukodystrophy using magnetization transfer imaging.

H. Moser, E. Melhem, G. Raymond, 1996, AJR. American journal of roentgenology.

Application of “ High-Performance ” LiquidChromatographyto the Study of Sphingolipidoses

H. Moser, D. Wenger, E. Pyeritz, 2004 .

Adrenomyeloneuropathy: A Neuropathologic Review Featuring Its Noninflammatory Myelopathy

H. Moser, A. Moser, C. Raine, 2000, Journal of neuropathology and experimental neurology.

CYTOKINES AND INFLAMMATORY DEMYELINATIVE LESIONS IN ADRENOLEUKODYSTROPHY AND MULTIPLE SCLEROSIS

H. Moser, S. Wesselingh, D. Griffin, 1993 .

Quantitative magnetization transfer characteristics of the human cervical spinal cord in vivo: Application to Adrenomyeloneuropathy

H. Moser, X. Golay, G. Raymond, 2009, Magnetic resonance in medicine.

Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids. 1981.

H. Moser, Y. Kishimoto, W. Chen, 1998, Neurology.

A new inborn lysosomal disease.

H. Moser, 1970, The New England journal of medicine.

Adrenoleukodystrophy: new approaches to a neurodegenerative disease.

H. Moser, G. Raymond, Prachi Dubey, 2005, JAMA.

Management of heritable disorders of the urea cycle and of Refsum's and Fabry's diseases.

H. Moser, S. Brusilow, H. Braine, 1979, Progress in clinical and biological research.